Chapter 02 The Proof of Concept

 Lab 69 - 8:15 AM

Aris's domain was Lab 69. A medium-sized room that had cost Warren Center nearly two million dollars to equip. Three temperature-controlled incubators along the back wall. A flow cytometer sat beside a fluorescent microscope, both connected to a workstation that logged every keystroke, every result, every deviation.

But the centerpiece. Her pride, her obsession, her potential legacy, stood in the middle of the room: a custom-built gene editing workstation centered around a Lonza 4D-Nucleofector, modified with an in-house electroporation chamber she had designed herself. Beside it, a real-time qPCR thermocycler sat connected to a monitor displaying telomere length assays in green peaks.

Aris had been working on telomere restoration for seven years. The science was simple in theory, brutal in practice: every time a cell divided, the protective caps at the ends of its chromosomes, the telomeres, got a little shorter. Eventually, they got too short. Cell stopped dividing and body aged. It was the biological clock, ticking down to zero.

She was trying to make it tick backward.

The approach was complex: targeted gene therapy using a modified viral vector to deliver telomerase, the enzyme that rebuilds telomeres. She had spent years refining the delivery mechanism, testing it on cell cultures, then on animal models, then, when the animal trials showed no adverse effects, on herself.

That had been three years ago.

She was forty-two now. She looked thirty. Her blood work showed telomere lengths consistent with someone in their late twenties. Her joints didn't ache. Her vision hadn't changed. She had, by every measurable metric, reversed her biological age by over a decade.

But that was just the first generation.

The second generation, the one she was working on now was more elegant. Instead of viral delivery, she had developed a lipid nanoparticle formulation containing modified mRNA encoding for TERT, wrapped in a proprietary polymer coating that targeted senescent cell surface markers. The LNPs would home in on aging cells, deliver the mRNA, and the cells would produce telomerase for approximately 72 hours. Long enough to extend telomeres, short enough to minimize cancer risk.

The animal trials had been promising. Aged mice showed restored fur density, improved wound healing, and a 30% extension of median lifespan with no increase in tumor incidence.

But mice weren't humans.

And humans, specifically, the people who funded Warren Center, were impatient.

----------------

Aris stood at the biosafety cabinet, her hands buried in thick rubber gloves, manipulating a 96-well plate. Each well contained CD34+ hematopoietic stem cells, isolated from donor blood, purified by magnetic bead separation, and cultured in a carefully balanced cocktail of growth factors.

She was adding the vector. The AAV-hTERT. A colorless liquid, indistinguishable from water, that represented seven years of her life.

"Transduction efficiency on the last batch was sixty percent," Sarah said from the adjacent workstation. She was reviewing flow cytometry data. "Which is better than the fifty-one percent we got from Donor 447, but still below the threshold for therapeutic relevance."

"Threshold is seventy percent," Aris replied without looking up. "We're not there yet."

"We're not close." Sarah swiveled in her chair. "Aris, we've tried three different capsid serotypes, two different promoters, and four different dosing regimens. The only time we hit seventy percent was with—"

"Don't say it."

"—with your cells."

Aris set down her pipette and turned to face her assistant. 

Sarah Mendez was twenty-six, with dark curly hair perpetually escaping her ponytail and eyes that missed nothing. She had been assigned to Aris four years ago by the Warren Center's board of directors, and she had been honest about it from day one.

They had been friends ever since.

"My cells are an outlier," Aris said, "You know that. The mutation profile is unique. The epigenetic markers are—"

"A one-off. I know." Sarah sighed, "But the board doesn't care about one-offs. They care about results. And the only results we have that look remotely promising came from a sample that we can't publish, can't replicate, and can't explain."

Aris was quiet for a moment. 

"How much do they know?"

"About your personal samples? Nothing. I've kept that data separate, just like you asked. But they're getting impatient, Aris. The quarterly report is due next week."

"How bad things with the directors board?" 

"Not bad. Just... not good enough. We need to give them something. We are below the seventy percent threshold. The board's not going to be impressed."

Aris leaned back in her chair.

"We'll give them the best results from today. The promising early data from the modified capsid. The new promoter designs."

 "That's not a breakthrough, Aris. That's a progress report."

"Progress is progress."

Sarah held up a hand. "I told you on day one: I'm here to monitor your progress for the board, but I'm also your friend. Those two things don't have to be in conflict. But you need to give me something I can work with. Something real. Something that isn't just 'we're getting closer.'"

Aris was quiet for a long moment. 

"Okay, fine. Run the assay again. The one with the new promoter. Use the higher viral titer. Double the incubation time."

"That's not protocol."

"Protocol hasn't worked. Let's try something that isn't protocol."

 "Fine. But if this fails—"

"Then we fail faster and try again." Aris stood up. "I'm going to get some air. Call me when the results are in."

"Results won't be ready for two hours."

"Then call me in two hours."

---------------------

Lab 69 - 06:45 PM

Two hours and eleven minutes later, the results came in.

Aris was back at her workstation, watching the screen as Sarah walked her through the data. The numbers were promising. Not a breakthrough. But something.

"Transduction efficiency hit sixty-three percent," Sarah said, "That's the highest we've ever seen in donor cells. And telomere elongation is at twelve percent above baseline."

"Twelve percent. That's promising."

"That's something. It's not seventy. It's not therapeutic. But it's proof of concept. It's enough to show the board that we're making real progress."

Aris allowed herself a smile. "Put together a summary. This should keep those old geezers off our backs for few more months."

Aris stood up and stretched. Her back cracked. Her neck popped. She felt every one of her forty-two years, even if she didn't look them. "Send me the draft tonight. I'll review it in the morning."

"You're leaving?"

"The day is over, Sarah. Even mad scientists need to eat."

 Sarah waved her toward the door. "I'll lock up. And Aris?"

Aris turned.

"Sixty-three percent. That's real progress. You should be proud."

"I am, Sarah. It might not show it, but I am."

-------------------

Security Desk - 07:15 PM

Leo was leaning against the wall outside the security office, arms crossed, a lazy grin on his face. 

"There she is. The woman who doesn't age. So? Ready for that drink?"

"I'm ready for something. Preferably something that stops my brain from spinning out of control for a few hours."

"Say no more, Doc. I already talked to Maka. She's got a few bottles of that good stuff stashed in the cafeteria. The real good stuff. The kind she only brings out when someone's had a day."

"What kind?"

"Red. Strong. Italian, I think. She said something about a vineyard her cousin knows. Also, she said she'd find a candle. You know. To set the mood."

 "The mood, huh."

"The romantic mood." Leo spread his arms. "I'm taking you on a date, Thorne. The fanciest date this bunker has ever seen. Candlelight. Fine wine. The subtle aroma of industrial disinfectant. What more could a woman want?"

"A raise. A success, and many, many other things."

"Best I can do is free coffee tomorrow morning."

"Deal."

They were still laughing when Chen walked in. She was scrolling through her phone, her thumbs moving at lightning speed.

"Chen," Leo said. "You coming?"

Chen looked up. "Yeah, I'll join. Just gotta finish something first."

"Posting another video?"

"Fitness video. Social media. I did my workout. Lighting in loading dock is actually really good. Lots of natural bounce from concrete."

Leo gave her a long, slow side-eye. Then he looked at Aris. "Did you hear that? She's bragging about messing around during work hours. In front of the second-in-command of this entire facility."

Aris shrugged. "I didn't hear anything. My ears stopped working after the third grant proposal."

"See?" Chen smiled. "Dr. Thorne is cool."

"Dr. Thorne is an enabler," Leo muttered. "Fine. Post your video. But don't take too long. I'm not drinking alone with a candle. That's just sad."

Suddenly, a red warning light start flashing on the monitor.

"Shit, a warning light come up. I need to go check it out. Talk about bad timing."

Aris shook her head, smiling. "I'll go hold a spot. Don't take too long, or I might drink all the wine alone."

"You wouldn't."

"Try me."

She walked toward the cafeteria, leaving Leo standing at his desk, watching her go.

--------------------

Warren Center's Cafeteria

It was a sad, functional room on Level 2. Gray tables. Gray chairs. A coffee machine. But tonight, Maka had done what she could.

A small table in the corner had been cleared. A single candle flickered in the center next to a single rose in a tall glass. Two plastic cups sat beside an open bottle of dark red wine. The label was handwritten in Italian. 'Sono tua. Per stasera.' The cork was already out.

Aris sat alone, the bottle half empty.

She wasn't drinking fast. She was drinking the way someone drinks when they're trying to feel something and can't quite reach it.

The wine was good. Rich. She could taste it, sort of. But the warmth in her chest was distant. Muffled. Like feeling a fire through a thick glass window.

She poured another glass.